Local and systemic responses to SARS-CoV-2 infection in children and adults.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
02 2022
Historique:
received: 06 03 2021
accepted: 14 12 2021
pubmed: 23 12 2021
medline: 24 2 2022
entrez: 22 12 2021
Statut: ppublish

Résumé

It is not fully understood why COVID-19 is typically milder in children

Identifiants

pubmed: 34937051
doi: 10.1038/s41586-021-04345-x
pii: 10.1038/s41586-021-04345-x
pmc: PMC8828466
mid: NIHMS1775797
doi:

Substances chimiques

Interferons 9008-11-1

Types de publication

Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

321-327

Subventions

Organisme : Medical Research Council
ID : MC_PC_17230
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/W014556/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT211276/Z/18/Z
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : P01 AG049665
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI135964
Pays : United States
Organisme : NHLBI NIH HHS
ID : P01 HL154998
Pays : United States
Organisme : Medical Research Council
ID : MR/S036113/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_20022
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S005579/1
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : R01 HL149883
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL153122
Pays : United States
Organisme : Medical Research Council
ID : MR/S035842/1
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : R01 HL153312
Pays : United States
Organisme : Medical Research Council
ID : MR/K017047/1
Pays : United Kingdom
Organisme : NCATS NIH HHS
ID : UL1 TR001422
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL076139
Pays : United States
Organisme : Medical Research Council
ID : MR/R015635/1
Pays : United Kingdom

Investigateurs

G R Scott Budinger (GRS)
Helen K Donnelly (HK)
Nikolay S Markov (NS)
Ziyan Lu (Z)

Informations de copyright

© 2021. The Author(s).

Références

Swann, O. V. et al. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study. Brit. Med. J. 370, m3249 (2020).
pubmed: 32960186 doi: 10.1136/bmj.m3249
Castagnoli, R. et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review. JAMA Pediatr. 174, 882–889 (2020).
pubmed: 32320004 doi: 10.1001/jamapediatrics.2020.1467
Ledford, H. Deaths from COVID ‘incredibly rare’ among children. Nature 595, 639–639 (2021).
doi: 10.1038/d41586-021-01897-w
Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271–280 (2020).
pubmed: 32142651 pmcid: 7102627 doi: 10.1016/j.cell.2020.02.052
Pang, L. et al. Influence of aging on deterioration of patients with COVID-19. Aging 12, 26248–26262 (2020).
pubmed: 33232272 pmcid: 7803552 doi: 10.18632/aging.202136
Muus, C. et al. Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics. Nat. Med.27, 546–559 (2021).
pubmed: 33654293 pmcid: 9469728 doi: 10.1038/s41591-020-01227-z
Sungnak, W. et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat. Med. 26, 681–687 (2020).
pubmed: 32327758 pmcid: 8637938 doi: 10.1038/s41591-020-0868-6
Bunyavanich, S., Do, A. & Vicencio, A. Nasal gene expression of angiotensin-converting enzyme 2 in children and adults. JAMA 323, 2427–2429 (2020).
pubmed: 32432657 pmcid: 7240631 doi: 10.1001/jama.2020.8707
Saheb Sharif-Askari, N. et al. Airways expression of SARS-CoV-2 receptor, ACE2, and TMPRSS2 is lower in children than adults and increases with smoking and COPD. Mol. Ther. Methods Clin. Dev. 18, 1–6 (2020).
pubmed: 32537478 pmcid: 7242205 doi: 10.1016/j.omtm.2020.05.013
Koch, C. M. et al. Age-related differences in the nasal mucosal immune response to SARS-CoV-2. Am. J. Respir. Cell Mol. Biol. https://doi.org/10.1165/rcmb.2021-0292OC (2021).
Loske, J. et al. Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children. Nat. Biotechnol. https://doi.org/10.1038/s41587-021-01037-9 (2021).
Schultze, J. L. & Aschenbrenner, A. C. COVID-19 and the human innate immune system. Cell 184, 1671–1692 (2021).
pubmed: 33743212 pmcid: 7885626 doi: 10.1016/j.cell.2021.02.029
Schoggins, J. W. Interferon-stimulated genes: what do they all do? Annu. Rev. Virol. 6, 567–584 (2019).
pubmed: 31283436 doi: 10.1146/annurev-virology-092818-015756
Ziegler, C. G. K. et al. Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19. Cell 184, 4713–4733 (2021).
pubmed: 34352228 pmcid: 8299217 doi: 10.1016/j.cell.2021.07.023
Hadjadj, J. et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369, 718–724 (2020).
pubmed: 32661059 pmcid: 7402632 doi: 10.1126/science.abc6027
Wang, E. Y. et al. Diverse functional autoantibodies in patients with COVID-19. Nature 595, 283–288 (2021).
pubmed: 34010947 doi: 10.1038/s41586-021-03631-y
Major, J. et al. Type I and III interferons disrupt lung epithelial repair during recovery from viral infection. Science 369, 712–717 (2020).
pubmed: 32527928 pmcid: 7292500 doi: 10.1126/science.abc2061
Broggi, A. et al. Type III interferons disrupt the lung epithelial barrier upon viral recognition. Science 369, 706–712 (2020).
pubmed: 32527925 pmcid: 7292499 doi: 10.1126/science.abc3545
Berlin, D. A., Gulick, R. M. & Martinez, F. J. Severe COVID-19. N. Engl. J. Med. 383, 2451–2460 (2020).
pubmed: 32412710 doi: 10.1056/NEJMcp2009575
Liao, M. et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat. Med. 26, 842–844 (2020).
pubmed: 32398875 doi: 10.1038/s41591-020-0901-9
Wilk, A. J. et al. A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nat. Med. 26, 1070–1076 (2020).
pubmed: 32514174 pmcid: 7382903 doi: 10.1038/s41591-020-0944-y
Zhang, J.-Y. et al. Single-cell landscape of immunological responses in patients with COVID-19. Nat. Immunol. 21, 1107–1118 (2020).
pubmed: 32788748 doi: 10.1038/s41590-020-0762-x
Stephenson, E. et al. Single-cell multi-omics analysis of the immune response in COVID-19. Nat. Med. 27, 904–916 (2021).
pubmed: 33879890 pmcid: 8121667 doi: 10.1038/s41591-021-01329-2
Pierce, C. A. et al. Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients. Sci. Transl. Med. 12, eabd5487 (2020).
pubmed: 32958614 pmcid: 7658796 doi: 10.1126/scitranslmed.abd5487
Weisberg, S. P. et al. Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum. Nat. Immunol. 22, 25–31 (2021).
pubmed: 33154590 doi: 10.1038/s41590-020-00826-9
Deprez, M. et al. A single-cell atlas of the human healthy airways. Am. J. Respir. Crit. Care Med. 202, 1636–1645 (2020).
pubmed: 32726565 doi: 10.1164/rccm.201911-2199OC
Montoro, D. T. et al. A revised airway epithelial hierarchy includes CFTR-expressing ionocytes. Nature 560, 319–324 (2018).
pubmed: 30069044 pmcid: 6295155 doi: 10.1038/s41586-018-0393-7
Chua, R. L. et al. COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis. Nat. Biotechnol. 38, 970–979 (2020).
pubmed: 32591762 doi: 10.1038/s41587-020-0602-4
Grant, R. A. et al. Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia. Nature 590, 635–641 (2021).
pubmed: 33429418 pmcid: 7987233 doi: 10.1038/s41586-020-03148-w
Ziegler, C. G. K. et al. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell 181, 1016–1035 (2020).
pubmed: 32413319 pmcid: 7252096 doi: 10.1016/j.cell.2020.04.035
Wang, W. et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA 323, 1843–1844 (2020).
pubmed: 32159775 pmcid: 7066521
Yu, F. et al. Quantitative detection and viral load analysis of sars-cov-2 in infected patients. Clin. Infect. Dis. 71, 793–798 (2020).
pubmed: 32221523 doi: 10.1093/cid/ciaa345
Vieira Braga, F. A. et al. A cellular census of human lungs identifies novel cell states in health and in asthma. Nat. Med. 25, 1153–1163 (2019).
pubmed: 31209336 doi: 10.1038/s41591-019-0468-5
Zhu, N. et al. Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells. Nat. Commun. 11, 3910 (2020).
pubmed: 32764693 pmcid: 7413383 doi: 10.1038/s41467-020-17796-z
Fang, Y. et al. Distinct stem/progenitor cells proliferate to regenerate the trachea, intrapulmonary airways and alveoli in COVID-19 patients. Cell Res. 30, 705–707 (2020).
pubmed: 32606347 pmcid: 7325636 doi: 10.1038/s41422-020-0367-9
Ruiz García, S. et al. Novel dynamics of human mucociliary differentiation revealed by single-cell RNA sequencing of nasal epithelial cultures. Development 146, dev177428 (2019).
pubmed: 31558434 pmcid: 6826037 doi: 10.1242/dev.177428
Ygberg, S. & Nilsson, A. The developing immune system—from foetus to toddler. Acta Paediatr. 101, 120–127 (2012).
pubmed: 22003882 doi: 10.1111/j.1651-2227.2011.02494.x
Blanco-Melo, D. et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 181, 1036–1045 (2020).
pubmed: 32416070 pmcid: 7227586 doi: 10.1016/j.cell.2020.04.026
Chen, G. et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J. Clin. Invest. 130, 2620–2629 (2020).
pubmed: 32217835 pmcid: 7190990 doi: 10.1172/JCI137244
Aschenbrenner, A. C. et al. Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients. Genome Med. 13, 7 (2021).
pubmed: 33441124 pmcid: 7805430 doi: 10.1186/s13073-020-00823-5
Silvin, A. et al. Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19. Cell 182, 1401–1418 (2020).
pubmed: 32810439 pmcid: 7405878 doi: 10.1016/j.cell.2020.08.002
Galani, I.-E. et al. Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison. Nat. Immunol. 22, 32–40 (2021).
pubmed: 33277638 doi: 10.1038/s41590-020-00840-x
Lee, J. S. et al. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19. Sci. Immunol. 5, eabd1554 (2020).
pubmed: 32651212 pmcid: 7402635 doi: 10.1126/sciimmunol.abd1554
Diebold, S. S. et al. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature 424, 324–328 (2003).
pubmed: 12819664 doi: 10.1038/nature01783
Saichi, M. et al. Single-cell RNA sequencing of blood antigen-presenting cells in severe COVID-19 reveals multi-process defects in antiviral immunity. Nat. Cell Biol. 23, 538–551 (2021).
pubmed: 33972731 doi: 10.1038/s41556-021-00681-2
Zhou, R. et al. Acute SARS-CoV-2 infection impairs dendritic cell and T cell responses. Immunity 53, 864–877 (2020).
pubmed: 32791036 pmcid: 7402670 doi: 10.1016/j.immuni.2020.07.026
Lokugamage, K. G. et al. Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV. J. Virol. 94, e01410-20 (2020).
pubmed: 32938761 pmcid: 7654262 doi: 10.1128/JVI.01410-20
Schurink, B. et al. Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study. Lancet Microbe 1, e290–e299 (2020).
pubmed: 33015653 pmcid: 7518879 doi: 10.1016/S2666-5247(20)30144-0
Kumar, B. V., Connors, T. J. & Farber, D. L. Human T cell development, localization, and function throughout life. Immunity 48, 202–213 (2018).
pubmed: 29466753 pmcid: 5826622 doi: 10.1016/j.immuni.2018.01.007
Naylor, K. et al. The influence of age on T cell generation and TCR diversity. J. Immunol. 174, 7446–7452 (2005).
pubmed: 15905594 doi: 10.4049/jimmunol.174.11.7446
Hagai, T. et al. Gene expression variability across cells and species shapes innate immunity. Nature 563, 197–202 (2018).
pubmed: 30356220 pmcid: 6347972 doi: 10.1038/s41586-018-0657-2
Li, S. et al. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation. Signal Transduct. Target. Ther. 5, 235 (2020).
pubmed: 33037188 pmcid: 7545816 doi: 10.1038/s41392-020-00334-0
Lee, P. Y. et al. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children. J. Clin. Invest. 130, 5942–5950 (2020).
pubmed: 32701511 pmcid: 7598077 doi: 10.1172/JCI141113
Worlock, K. B. Cell dissociation from nasal, bronchial and tracheal brushings with cold-active protease for single-cell RNA-seq. protocols.io https://doi.org/10.17504/protocols.io.btpunmnw (2021).
Lun, A. T. L. et al. EmptyDrops: distinguishing cells from empty droplets in droplet-based single-cell RNA sequencing data. Genome Biol. 20, 63 (2019).
pubmed: 30902100 pmcid: 6431044 doi: 10.1186/s13059-019-1662-y
Wolock, S. L., Lopez, R. & Klein, A. M. Scrublet: computational identification of cell doublets in single-cell transcriptomic data. Cell Syst. 8, 281–291 (2019).
pubmed: 30954476 pmcid: 6625319 doi: 10.1016/j.cels.2018.11.005
Pijuan-Sala, B. et al. A single-cell molecular map of mouse gastrulation and early organogenesis. Nature 566, 490–495 (2019).
pubmed: 30787436 pmcid: 6522369 doi: 10.1038/s41586-019-0933-9
Popescu, D.-M. et al. Decoding human fetal liver haematopoiesis. Nature 574, 365–371 (2019).
pubmed: 31597962 pmcid: 6861135 doi: 10.1038/s41586-019-1652-y
Traag, V. A., Waltman, L. & van Eck, N. J. From Louvain to Leiden: guaranteeing well-connected communities. Sci. Rep. 9, 5233 (2019).
pubmed: 30914743 pmcid: 6435756 doi: 10.1038/s41598-019-41695-z
Wolf, F. A., Angerer, P. & Theis, F. J. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 19, 15 (2018).
pubmed: 29409532 pmcid: 5802054 doi: 10.1186/s13059-017-1382-0
Young, M. D. & Behjati, S. SoupX removes ambient RNA contamination from droplet-based single-cell RNA sequencing data. Gigascience 9, giaa151 (2020).
pubmed: 33367645 pmcid: 7763177 doi: 10.1093/gigascience/giaa151
Wood, D. E., Lu, J. & Langmead, B. Improved metagenomic analysis with Kraken 2. Genome Biol. 20, 257 (2019).
pubmed: 31779668 pmcid: 6883579 doi: 10.1186/s13059-019-1891-0
Wood, D. kraken2, https://github.com/DerrickWood/kraken2 (2018).
Bost, P. Viral-Track, https://github.com/PierreBSC/Viral-Track (2020).
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
pubmed: 23104886 doi: 10.1093/bioinformatics/bts635
Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841–842 (2010).
pubmed: 20110278 pmcid: 2832824 doi: 10.1093/bioinformatics/btq033
Quinlan, A. bedtools2, https://github.com/arq5x/bedtools2 (2021).
Polański, K. et al. BBKNN: fast batch alignment of single cell transcriptomes. Bioinformatics 36, 964–965 (2020).
pubmed: 31400197 doi: 10.1093/bioinformatics/btz625
Bergen, V., Lange, M., Peidli, S., Wolf, F. A. & Theis, F. J. Generalizing RNA velocity to transient cell states through dynamical modeling. Nat. Biotechnol. 38, 1408–1414 (2020).
pubmed: 32747759 doi: 10.1038/s41587-020-0591-3
Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005).
pubmed: 16199517 pmcid: 1239896 doi: 10.1073/pnas.0506580102
Heaton, H. et al. Souporcell: robust clustering of single-cell RNA-seq data by genotype without reference genotypes. Nat. Methods 17, 615–620 (2020).
pubmed: 32366989 doi: 10.1038/s41592-020-0820-1
McGinnis, C. S., Murrow, L. M. & Gartner, Z. J. DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst. 8, 329–337 (2019).
pubmed: 30954475 pmcid: 6853612 doi: 10.1016/j.cels.2019.03.003
Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177 1888–1902 (2019).
pubmed: 31178118 pmcid: 6687398 doi: 10.1016/j.cell.2019.05.031
Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289–1296 (2019).
pubmed: 31740819 pmcid: 6884693 doi: 10.1038/s41592-019-0619-0
Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573–3587 (2020).
doi: 10.1016/j.cell.2021.04.048
Reimand, J. et al. g:Profiler—a web server for functional interpretation of gene lists (2016 update). Nucleic Acids Res. 44, W83–W89 (2016).
pubmed: 27098042 pmcid: 4987867 doi: 10.1093/nar/gkw199
Cantuti-Castelvetri, L. et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science 370, 856–860 (2020).
pubmed: 33082293 pmcid: 7857391 doi: 10.1126/science.abd2985
Daly, J. L. et al. Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science 370, 861–865 (2020).
pubmed: 33082294 pmcid: 7612957 doi: 10.1126/science.abd3072
Wang, K. et al. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct. Target. Ther. 5, 283 (2020).
pubmed: 33277466 pmcid: 7714896 doi: 10.1038/s41392-020-00426-x
Tang, X. et al. Transferrin receptor is another receptor for SARS-CoV-2 entry. Preprint at https://doi.org/10.1101/2020.10.23.350348 (2020).
Young, A. M. H. et al. A map of transcriptional heterogeneity and regulatory variation in human microglia. Nat. Genet. 53, 861–868 (2021).
pubmed: 34083789 pmcid: 7610960 doi: 10.1038/s41588-021-00875-2
Sturm, G. et al. Scirpy: a Scanpy extension for analyzing single-cell T-cell receptor-sequencing data. Bioinformatics 36, 4817–4818 (2020).
pubmed: 32614448 pmcid: 7751015 doi: 10.1093/bioinformatics/btaa611

Auteurs

Masahiro Yoshida (M)

UCL Respiratory, Division of Medicine, University College London, London, UK.
Division of Respiratory Diseases, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.

Kaylee B Worlock (KB)

UCL Respiratory, Division of Medicine, University College London, London, UK.

Ni Huang (N)

Wellcome Sanger Institute, Cambridge, UK.

Rik G H Lindeboom (RGH)

Wellcome Sanger Institute, Cambridge, UK.

Colin R Butler (CR)

NIHR Great Ormond Street BRC and UCL Institute of Child Health, London, UK.
Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.

Natsuhiko Kumasaka (N)

Wellcome Sanger Institute, Cambridge, UK.

Cecilia Dominguez Conde (C)

Wellcome Sanger Institute, Cambridge, UK.

Lira Mamanova (L)

Wellcome Sanger Institute, Cambridge, UK.

Liam Bolt (L)

Wellcome Sanger Institute, Cambridge, UK.

Laura Richardson (L)

Wellcome Sanger Institute, Cambridge, UK.

Krzysztof Polanski (K)

Wellcome Sanger Institute, Cambridge, UK.

Elo Madissoon (E)

Wellcome Sanger Institute, Cambridge, UK.
European Molecular Biology Laboratory, European Bioinformatics Institute, Cambridge, UK.

Josephine L Barnes (JL)

UCL Respiratory, Division of Medicine, University College London, London, UK.

Jessica Allen-Hyttinen (J)

UCL Respiratory, Division of Medicine, University College London, London, UK.

Eliz Kilich (E)

University College London Hospitals NHS Foundation Trust, London, UK.

Brendan C Jones (BC)

NIHR Great Ormond Street BRC and UCL Institute of Child Health, London, UK.
Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.

Angus de Wilton (A)

University College London Hospitals NHS Foundation Trust, London, UK.

Anna Wilbrey-Clark (A)

Wellcome Sanger Institute, Cambridge, UK.

Waradon Sungnak (W)

Wellcome Sanger Institute, Cambridge, UK.

J Patrick Pett (JP)

Wellcome Sanger Institute, Cambridge, UK.

Juliane Weller (J)

Wellcome Sanger Institute, Cambridge, UK.

Elena Prigmore (E)

Wellcome Sanger Institute, Cambridge, UK.

Henry Yung (H)

UCL Respiratory, Division of Medicine, University College London, London, UK.
University College London Hospitals NHS Foundation Trust, London, UK.

Puja Mehta (P)

UCL Respiratory, Division of Medicine, University College London, London, UK.
University College London Hospitals NHS Foundation Trust, London, UK.

Aarash Saleh (A)

Royal Free Hospital NHS Foundation Trust, London, UK.

Anita Saigal (A)

Royal Free Hospital NHS Foundation Trust, London, UK.

Vivian Chu (V)

Royal Free Hospital NHS Foundation Trust, London, UK.

Jonathan M Cohen (JM)

University College London Hospitals NHS Foundation Trust, London, UK.

Clare Cane (C)

Royal Free Hospital NHS Foundation Trust, London, UK.

Aikaterini Iordanidou (A)

Royal Free Hospital NHS Foundation Trust, London, UK.

Soichi Shibuya (S)

NIHR Great Ormond Street BRC and UCL Institute of Child Health, London, UK.

Ann-Kathrin Reuschl (AK)

UCL Division of Infection and Immunity, University College London, London, UK.

Iván T Herczeg (IT)

UCL Respiratory, Division of Medicine, University College London, London, UK.

A Christine Argento (AC)

Division of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Richard G Wunderink (RG)

Division of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Sean B Smith (SB)

Division of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Taylor A Poor (TA)

Division of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Catherine A Gao (CA)

Division of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Jane E Dematte (JE)

Division of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Gary Reynolds (G)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Muzlifah Haniffa (M)

Wellcome Sanger Institute, Cambridge, UK.
Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Georgina S Bowyer (GS)

Department of Medicine, University of Cambridge, Cambridge, UK.

Matthew Coates (M)

Department of Medicine, University of Cambridge, Cambridge, UK.
Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Menna R Clatworthy (MR)

Wellcome Sanger Institute, Cambridge, UK.
Department of Medicine, University of Cambridge, Cambridge, UK.

Fernando J Calero-Nieto (FJ)

Wellcome, MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.

Berthold Göttgens (B)

Wellcome, MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.

Christopher O'Callaghan (C)

NIHR Great Ormond Street BRC and UCL Institute of Child Health, London, UK.
Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.

Neil J Sebire (NJ)

NIHR Great Ormond Street BRC and UCL Institute of Child Health, London, UK.
Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.

Clare Jolly (C)

UCL Division of Infection and Immunity, University College London, London, UK.

Paolo De Coppi (P)

NIHR Great Ormond Street BRC and UCL Institute of Child Health, London, UK.
Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.

Claire M Smith (CM)

NIHR Great Ormond Street BRC and UCL Institute of Child Health, London, UK.

Alexander V Misharin (AV)

Division of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Sam M Janes (SM)

UCL Respiratory, Division of Medicine, University College London, London, UK.
University College London Hospitals NHS Foundation Trust, London, UK.

Sarah A Teichmann (SA)

Wellcome Sanger Institute, Cambridge, UK.
Department of Physics, Cavendish Laboratory, University of Cambridge, Cambridge, UK.

Marko Z Nikolić (MZ)

UCL Respiratory, Division of Medicine, University College London, London, UK. m.nikolic@ucl.ac.uk.
University College London Hospitals NHS Foundation Trust, London, UK. m.nikolic@ucl.ac.uk.

Kerstin B Meyer (KB)

Wellcome Sanger Institute, Cambridge, UK. km16@sanger.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH